Long-term outcome of anti-neutrophil cytoplasm antibody-associated glomerulonephritis: evaluation of the international histological classification and other prognostic factors.
about
Targeting the tyrosine kinase signalling pathways for treatment of immune-mediated glomerulonephritis: from bench to bedside and beyond.Linking classification and therapeutic management of vasculitides.Older patients with ANCA-associated vasculitis and dialysis dependent renal failure: a retrospective study.ANCA positive crescentic glomerulonephritis outcome in a Central East European cohort: a retrospective study.Necrotizing and crescentic glomerulonephritis presenting with preserved renal function in patients with underlying multisystem autoimmune disease: a retrospective case series.Correlation of disease activity in proliferative glomerulonephritis with glomerular spleen tyrosine kinase expression.Proteinase 3-ANCA Vasculitis versus Myeloperoxidase-ANCA Vasculitis.Predictors of Poor Outcome in ANCA-Associated Vasculitis (AAV).Prognostic Value of Histologic Classification of ANCA-Associated Glomerulonephritis.ANCA-associated vasculitis with renal involvement.Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients.Treatment and clinicopathological characteristics of lupus nephritis with anti-neutrophil cytoplasmic antibody positivity: a case-control study.Long-term renal outcome in pediatric glomerulonephritis associated with crescent formation.Histopathologic classification of anti-neutrophil cytoplasmic antibody-associated glomerulonephritis: achievements, limitations, and perspectives.[S1 guidelines Diagnostics and treatment of ANCA-associated vasculitis].Interstitial Immunostaining and Renal Outcomes in Antineutrophil Cytoplasmic Antibody-Associated Glomerulonephritis.Risk Factors for Renal Survival in Chinese Patients with Myeloperoxidase-ANCA-Associated GN.End-stage renal disease in ANCA-associated vasculitis.Antineutrophil cytoplasmic antibody associated vasculitides with renal involvement: Open challenges in the remission induction therapy.Impact of Proteinase 3 versus Myeloperoxidase Positivity on Risk of End-Stage Renal Disease in ANCA-Associated Glomerulonephritis Stratified by Histological Classification: A Population-Based Cohort Study.Prognostic Factors in Anti-Neutrophil Cytoplasmic Antibody-Associated Glomerulonephritis with Severe Glomerular Sclerosis: A National Registry-Based Cohort Study.Prognosis and Histological Classification in Elderly Patients with ANCA-Glomerulonephritis: A Registry-Based Cohort Study.Histopathological Classification-A Prognostic Tool for Rapidly Progressive GlomerulonephritisPrognostic Factors for Survival and Relapse in ANCA-Associated Vasculitis with Renal Involvement: A Clinical Long-Term Follow-Up Study
P2860
Q33620537-E91C984A-82FE-47EA-A77F-0C10B6B1D3DAQ35672892-D8750918-3925-41BB-AE04-1A7F9CD288CBQ35673484-7216A800-25B2-4A11-9E7A-4D88B228FA92Q35678050-E8772948-9187-40CA-AC3B-9B7BCCADDE17Q35767701-70ACEF05-8102-4D22-A18F-47D8A4AB43C2Q35809151-1B61D791-0068-4FC2-8C07-BA42907C57A0Q36104863-8ED9AAE0-5A74-4EA5-AEC6-CA2B45073F6DQ38798628-8BBB45A0-E610-4B32-94D4-7988477D28DFQ38802028-63A35D45-A85A-4C14-A95A-0B35A832611EQ39339897-8277BB33-0052-41C4-9CFC-378E77A2242FQ41491056-AE6A7523-334F-480B-8FBD-C787ED996EEEQ42697904-A1B2A309-0B27-40C9-99AA-E9BBC93BBD2CQ47660593-F7D20FD1-D98E-4A61-BD9D-515E3516D8ACQ48634139-1A23158E-C895-41CB-8CE2-37D207CF8CD0Q50076914-CCC0A317-F15D-4215-9ABF-9F1E84977973Q50206075-BB452010-565A-48F7-AF0C-03FB1B8B1D59Q50918659-976D064A-5EAC-4CC5-A897-8288528F43B6Q53513595-CF14728A-FEE7-44D0-BD40-A0F78109986FQ55340553-C6FFC954-5101-44A9-822C-59AEC8D7C2FFQ55395279-9ED29803-18C9-46D8-A637-55749A64F275Q55404208-07724A99-BBC8-4CF0-8FDC-BE392211AB21Q55405504-9800DA34-76B9-4370-A19F-5B9221609604Q57825808-ED850216-8937-46C2-9387-361ADA2E3A29Q58555878-A410CF98-3477-4E39-81E8-39B246A2E04B
P2860
Long-term outcome of anti-neutrophil cytoplasm antibody-associated glomerulonephritis: evaluation of the international histological classification and other prognostic factors.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Long-term outcome of anti-neut ...... and other prognostic factors.
@en
Long-term outcome of anti-neut ...... and other prognostic factors.
@nl
type
label
Long-term outcome of anti-neut ...... and other prognostic factors.
@en
Long-term outcome of anti-neut ...... and other prognostic factors.
@nl
prefLabel
Long-term outcome of anti-neut ...... and other prognostic factors.
@en
Long-term outcome of anti-neut ...... and other prognostic factors.
@nl
P2093
P2860
P356
P1476
Long-term outcome of anti-neut ...... and other prognostic factors.
@en
P2093
Alan D Salama
Anisha Tanna
Beatriz Rodriquez-Cubillo
Charles D Pusey
Frederick W K Tam
Jeremy B Levy
Laura Guarino
Megan Griffith
Ruth M Tarzi
Terence Cook
P2860
P304
P356
10.1093/NDT/GFU237
P407
P50
P577
2014-07-12T00:00:00Z